Daiichi Sankyo Company, Ltd.

3-5-1, Nihonbashi-honcho
Chuo-ku
Tokyo
103-8426

Tel: +81-3-6225-1111

Show jobs for this employer

About Daiichi Sankyo Company, Ltd.

Daiichi Sankyo is focused on the discovery and development of novel oncology agents with the goal of delivering first-in-class and best-in-class treatments that address unmet medical needs. The oncology pipeline of Daiichi Sankyo continues to grow and currently includes both small molecules and monoclonal antibodies with novel targets in both solid and hematological cancers.
YEAR FOUNDED:
1899
LEADERSHIP:
CEO: Joji Nakayama
CLINICAL TRIAL:
Please click here for clinical trial information.
PRODUCTS:
All Products

132 articles with Daiichi Sankyo Company, Ltd.